Mingchen Deferred Long Term Liab from 2010 to 2025
| 002919 Stock | 16.48 0.14 0.84% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 19.1 M | Current Value 20 M | Quarterly Volatility 6.4 M |
Check Mingchen Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mingchen Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 211.7 M, Interest Expense of 4.4 M or Selling General Administrative of 18.6 M, as well as many indicators such as . Mingchen financial statements analysis is a perfect complement when working with Mingchen Health Valuation or Volatility modules.
Mingchen | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Mingchen Stock
Mingchen Health financial ratios help investors to determine whether Mingchen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mingchen with respect to the benefits of owning Mingchen Health security.